Stock analysts at SVB Leerink started coverage on shares of Belite Bio (NASDAQ:BLTE – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage set an “outperform” rating and a $25.00 price target on the stock. SVB Leerink’s price target would indicate a potential upside of 34.26% […]
Belite Bio (NASDAQ:BLTE – Get Rating) had its price target reduced by equities researchers at HC Wainwright from $58.00 to $55.00 in a research note issued on Monday, The Fly reports. HC Wainwright’s target price suggests a potential upside of 264.24% from the company’s previous close. HC Wainwright also issued estimates for Belite Bio’s Q1 […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw unusually-high trading volume on Monday . Approximately 5,918 shares were traded during trading, a decline of 40% from the previous session’s volume of 9,866 shares.The stock last traded at $26.15 and had previously closed at $25.54. Analysts Set New Price Targets A number of equities analysts […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 31,700 shares, an increase of 13.6% from the March 31st total of 27,900 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw strong trading volume on Wednesday . 12,780 shares changed hands during mid-day trading, an increase of 27% from the previous session’s volume of 10,062 shares.The stock last traded at $29.75 and had previously closed at $29.87. Analysts Set New Price Targets A number of analysts have […]